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Colorectal cancer is the third most common malignancy in males and the second most 
common in females, with significant variations in the worldwide distribution, and remains 
among four leading causes of cancer deaths overall, shows global cancer statistics. The 
highest incident rates are found in economically developed countries, whereas the lowest 
rates are noted in Africa and South-Central (Jemal et al., 2011). However, striking increase in 
colorectal cancer incident trends is observed in areas historically at low risk, such as Spain 
and some Eastern European (the Czech Republic and Slovakia) and Eastern Asian countries 
(Japan). On the other hand, generally high incident rates over the past several decades are 
going down in the Unites States (Center et al., 2009). These recent “perturbations” in 
colorectal cancer trends probably result from a combination of risk factors, including 
obesity, sedentary lifestyle, increased prevalence of smoking, excessive alcohol consumption 
and “westernization” in dietary habits - a diet rich in red and processed meat and low intake 
of fruits and vegetables (Center et al., 2009; Chao et al., 2005; Jemal et al., 2011). Decreasing 
incident and mortality rates are mainly associated with colorectal cancer screening and 
improved treatment. 
Prognosis of these patients depends on the stage of the cancer at diagnosis. As the AJCC 
(American Joint Committee on Cancer) stage increases from stage I to stage IV, the 5-year 
overall survival rates decrease dramatically, reaching 90% if the disease is detected early 
when still localized, though just 39% of colorectal cancers are found at this stage. Almost 
25% of patients have a metastatic disease at diagnosis, with a 5-year survival of less than 
10% (Goldberg et al., 2007). The primary treatment for colorectal cancer is surgical resection. 
More than two-thirds of patients undergo radical surgery, but 30-50% of patients who 
present with stage II or III tumors ultimately experience disease recurrence and distant 
metastases (Rodriguez-Moranta et al., 2006). Although a broader base of treatment options 
for metastatic colorectal cancer (mCRC) has evolved in recent years, 50 - 70% of mCRC 
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patients still cannot be subjected to radical resection of metastases and are candidates for 
palliative therapy only (Fornaro et al., 2010). 
The drugs commonly used to treat mCRC are fluoropyrimidines (fluorouracil and 
capecitabine), irinotecan – a semisynthetic derivative of the natural alkaloid camptothecin, 
and oxaliplatin – a diaminocyclohexane platinum compound. More recently, two 
monoclonal antibodies have been approved for the treatment of advanced stages of 
colorectal cancer. Bevacizumab, a humanized monoclonal antibody against vascular 
endothelial growth factor (VEGF), is broadly used in combination with fluoropyrimidine-
based chemotherapy. Cetuximab, a chimeric monoclonal antibody against the epidermal 
growth factor receptor (EGFR), is used as monotherapy or together with irinotecan in 
irinotecan-resistant patients (Hess et al., 2010; Tol and Punt, 2010; Van Cutsem et al., 2009). 
These chemotherapy agents have significantly improved the prognoses and median overall 
survival. However, chemotherapy drug resistance occurs in nearly all patients and remains 
the most frequent cause of treatment failure (Candeil et al., 2004; Dallas et al., 2009), calling 
for finding novel agents capable of killing drug-resistant colorectal cancer cells. 
2. Dietary compounds and cancer 
2.1 Cancer prevention by diet 
The possibility that fruit and vegetables might help to reduce the risk for various types of 
cancer raised great interest already in the 1970s. The first studies conducted to assess 
differences in cancer rates and diet between countries suggested that various dietary factors 
might have important effects on cancer risk (Armstrong and Doll, 1975; Bjelke, 1975). 
In 1992, an epidemiological research with 156 studies on connection between the 
consumption of fruit and vegetables and cancer concluded that persons with a low fruit and 
vegetable intake face up to twice the risk of developing cancer compared to those with a 
high intake (Block et al., 1992). Several years later, a joint report by the World Cancer 
Research Fund together with the American Institute of Cancer Research found ‘convincing’ 
evidence that a high fruit and vegetable intake would reduce cancer of the colon and rectum 
(AIRC, 1997).  
Unfortunately, 10 years later, an updated report released by the same organization and 
based on large prospective studies instead on case-control studies, downgraded these 
previous conclusions. The evidence that high intakes of fruit and/or vegetables decrease the 
risk for cancers of the mouth and pharynx, esophagus, stomach, colorectum and lung were 
judged ‘probable’ or ‘limited- suggestive’, so researchers did not confirm the earlier results 
(AIRC, 2007). 
In a randomized dietary intervention trial, called The Polyp Prevention Trial, it was 
examined the effectiveness of a low-fat, high-fiber, high-fruit, and high-vegetable diet on 
adenoma recurrence. This study was the first to examine the association between flavonoid 
intake and colorectal adenoma recurrence. It was found that total flavonoid intake was not 
associated with colorectal adenoma recurrence, but they also detected during the trial a 
reduced risk of advanced adenoma recurrence with greater flavonol consumption (Bobe et 
al., 2008). 
The European Prospective Investigation into Cancer and Nutrition in 2009 suggested that a 
high consumption of fruit and vegetables is associated with a reduced risk of CRC, 
especially of colon cancer but differs according to smoking status. An inverse association for 
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never and former smokers and a statistically non significant positive association for current 
smokers was observed (van Duijnhoven et al., 2009). 
Key, on the other hand, by summarizing data recorded from large prospective studies or 
pooled analyses, recommended a diet which contains moderate amounts of fruit and 
vegetables in order to prevent deficiencies of any nutrients. Nevertheless, the available data 
suggest that, at least in relatively well-nourished populations, general increases in fruit and 
vegetable intake would not have much effect on cancer rates (Key, 2011). 
Due, at least in part, to their anti-oxidant and anti-inflammatory activities, epidemiologic 
studies suggest that the consumption of anthocyanins lowers the risk of cardiovascular 
disease, diabetes, arthritis and cancer (Prior and Wu, 2006). Their activities are associated to 
their action at different molecular level: direct ability to scavenge reactive oxygen species 
(Wang and Jiao, 2000) or to induce phase II antioxidant and detoxifying enzymes (Shih et al., 
2005; Shih et al., 2007). 
2.2 Dietary compounds and tumor progression 
Cancer cells differ from normal cells due to the following properties: unlimited replication 
potential, the absence of apoptosis, the absence of telomere shortening, angiogenesis and 
metastasis. Dietary compounds have been shown to affect molecular events involved in the 
initiation, promotion and progression of cancer, thereby inhibiting carcinogenesis. 
Furthermore, their inhibitory activity may ultimately suppress the final steps of 
carcinogenesis as well, namely angiogenesis and metastasis. The relationship between the 
frequency of consumption of vegetables and fruit and cancer risk is linked to a class of 
phytochemicals which flavonoids belong to.  
The unlimited replication potential of cancer cells is a result of the inactivation of tumour 
suppressor genes. For instance, mutated p21 gene products are no longer able to bind to 
cyclin, thus cyclin-dependent kinase remains active and cell division becomes uncontrolled. 
Targeting these protein kinases using natural products has been seen as a promising 
approach in solving the cancer menace (Omura et al., 1995; Yasuzawa et al., 1986). Although 
research on protein kinases is still at an early stage, there is enough evidence that dietary 
compounds have useful potency and specificity against protein kinases of medicinal 
importance.  
Resveratol has been shown by numerous reports to inhibit cell proliferation through the 
inhibition of cell-cycle progression at different stages (Aggarwal and Shishodia, 2006; Liang 
et al., 2003; Takagaki et al., 2005). Down-regulation of the cyclin D1/Cdk4 complex by 
resveratrol has been reported in colon cancer cell lines (Wolter et al., 2001) as well as 
resveratrol-induced G2 arrest through the inhibition of Cdk7 and Cdc2 kinases in colon 
carcinoma HT-29cells (Liang et al., 2003). Furthermore, an anthocyanin-rich extract caused 
cell cycle arrest and increased expression of the p27kip1 and p21WAF1/Cip1 genes and a 
60% cancer cell growth inhibition (Malik et al., 2003). 
Abnormalities in the ubiquitin-proteasome system have been implicated in many protein 
degradation disorders, including several types of cancer. This has made the proteasome an 
important target for anti-cancer drug discovery. Proteasome inhibitors can be categorized as 
synthetic and natural, where natural molecules are often more specific and potent than 
synthetic ones (D'Alessandro et al., 2009). Chen and colleagues showed that dietary 
flavonoids apigenin and quercetin inhibit proteasome, and this inhibition may contribute to 
their cancer-preventative effects (Chen et al., 2005). Furthermore, Kazi and colleagues also 
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showed that the tumor cell apoptosis-inducing ability of genistein (a soy flavonoid) is 
associated with its inhibition of proteosome activity (Kazi et al., 2003). 
Apoptosis is triggered when normal cells are worn out. In cancer cells, the telomerase 
activity allows them to evade apoptosis by stabilizing and elongating telomeres through 
synthesis of de novo telomeric DNA (Naasani et al., 2003). Telomerase activity has been 
identified in most human tumors (Kim et al., 1994). A high telomerase activity has been 
linked to the degree of malignancy and likelihood of tumor progression (Fujiwara et al., 
2000; Hiyama et al., 1995). Tea catechins, especially the degradation products of 
epigallocatechin gallate, epicatechin, quercetin, naringin and naringinin, have been found to 
inhibit telomerase activity (Naasani et al., 1998).  
Angiogenesis, one of the hallmarks of cancer, vital to tumor growth and metastasis, is 
characterized by growth of new capillaries from preexisting vessels (Folkman, 1995). Cancer 
cells release vascular epithelial growth factor (VEGF), an angiogenic cytokine which 
stimulates blood vessel growth. Inhibition of VEGF has therefore become a primary target 
for anti-angiogenic strategies, and inhibitors directed against either VEGF or its receptor 
VEGFR-2, have been demonstrated to prevent vascularization and growth of a large number 
of experimental tumor types (Labrecque et al., 2005; Underiner et al., 2004). Ellagic acid 
(naturally occurring phenolic constituent in fruits and nuts) has been shown to inhibit 
VEGF-induced migration of endothelial cells (Labrecque et al., 2005). Green tea catechins 
inhibit vascular endothelial growth factor receptor phosphorylation (Lamy et al., 2002), and 
resveratol also inhibits vascular endothelial growth factor (VEGF)-induced angiogenic 
effects in the human umbilical vein endothelial cells through the abrogation of VEGF-
mediated tyrosine phosphorylation of vascular endothelial (VE)-cadherin and its complex 
partner, b-catenin (Aggarwal and Shishodia, 2006; Lin et al., 2003). In addition, the flavonoid 
luteolin also inhibited both VEGF-induced survival and proliferation of the human 
umbilical vein endothelial cells (Bagchi et al., 2004). In vitro studies have shown that 
anthocyanin-rich berry extract formula exhibited a potent inhibitory effect on H2O2-induced 
VEGF expression. Anthocyanins suppress angiogenesis through the inhibition of H2O2- and 
tumor necrosis factor alpha (TNF-a)-induced VEGF expression, as well as through the 
inhibition of VEGF and VEGF receptor expression (Bagchi et al., 2004). 
Metastasis occurs when cancer cells invade blood and lymphatic vessels and are transported 
to other cells and tissues in the body. Cancer cells produce proteinase enzymes that allow 
them to invade blood and lymphatic vessels. The matrix metalloproteinases (MMP) are a 
group of proteolytic enzymes that degrade the extracellular matrix (ECM) components 
(Nabeshima et al., 2002). MMP-2 and MMP-9 are two important MMPs in cell invasion as 
cancerous tissues and tumor cells have shown increased levels and activities of both MMP-2 
and MMP-9 (Bernardo and Fridman, 2003).  
Proanthocyanidins and flavonoids from cranberry and other Vaccinium berries have been 
shown to inhibit the expression of MMPs involved in remodeling the extracellular matrix 
(Pupa et al., 2002). Curcumin inhibits MMP-2, which is implicated in the formation of loose 
and primitive looking meshwork formed by aggressive cancers such as melanoma and 
prostate cancers (Aggarwal and Shishodia, 2006). Resveratrol has been found to cause a 
dose-dependent inhibition of PMA (Phorbol Myristate Aacetate)-induced increases in MMP-
9 expression and activity and also the suppression of MMP-9 mRNA expression. 
Furthermore, Rose and colleagues found that phytochemicals from broccoli and rorripa 
have anti-invasive and anti-metalloproteinase activities (Rose et al., 2005). Purified ursolic 
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acid and hydroxycinnamate esters from cranberry fruit strongly inhibited expression of 
MMP-2 and MMP-9 activities at micromolar concentrations in fibrosarcoma cells (Cha et al., 
1996). Anthocyanins from mulberry fruits and highbush blueberry (V. angustifolium) 
inhibited MMP-2 and MMP-9 activities (Huang et al., 2008; Matchett et al., 2005; Matchett et 
al., 2006). Delphinidin can inhibit invasion of human fibrosarcoma cells through down-
regulation of MMP-2 and MMP-9, expression (Nagase et al., 1998). More recently, it has 
been demonstrated that black rice anthocyanins, cyanidin 3-glucoside and peonidin 3-
glucoside, significantly reduce the expression of MMP-9 in diverse types of cancer cells 
(Chen et al., 2006). Furthermore, it was also demonstrated that the activities of MMP-2 and -
9 were dose-dependently suppressed by anthocyanin treatment on HT-29 human colon 
cancer cells (Yun et al., 2010) and in HCT-116 human colon cancer cells through the 
activation of 38-MAPK and suppression of the PI3K/Akt pathway (Shin et al., 2011). 
2.3 Flavonoids 
Bioactive compounds that impart protective properties to plants against various 
pathological conditions are grouped under the name of phytochemicals. Active components 
of dietary phytochemicals which have been identified to protect against cancer include 
curcumin, resveratrol, diallyl sulfide, S-allyl cysteine, allicin, lycopene, capsaicin, diosgenin, 
6-gingerol, ellagic acid, ursolic acid, silymarin, anethol, eugenol, isoeugenol, dithiolthiones, 
isothiocyanates, indole-3-carbinol, protease inhibitors, saponins, phytosterols, inositol 
hexaphosphate, Vitamin C, D-limonene, lutein, folic acid, beta carotene, selenium, Vitamin 
E, flavonoids, and dietary fiber (Aggarwal and Shishodia, 2006).  
Flavonoids represent one of the largest groups of secondary metabolites whose name refers 
to a class of more than 6500 molecules based upon a 15-carbon skeleton (Harborne and 
Williams, 2000; Ververidis et al., 2007). They are divided into six major classes: flavanols, 
flavonones, flavones, isoflavones, flavonols and anthocyanins. Flavonoids are not 
synthesized in animal cells, thus their detection in animal tissues is indicative of plant 
ingestion (Mennen et al., 2008). Dietary flavonoids play an important role in cancer 
prevention and inhibition influencing various cellular processes, such as reactive oxygen 
species production and cell signal transduction pathways related to cellular proliferation, 
apoptosis, and angiogenesis (Yao et al., 2011).  
Flavonoids compounds are the most studied anticarcinogens among phytochemicals. 
Anthocyanins, a particular class of this group of molecules, are the most abundant flavonoid 
constituents of fruits and vegetables (Wang and Stoner, 2008). 
2.3.1 Anthocyanins: Chemistry  
Anthocyanins (Greek anthos = flower and kyanos = blue) are water-soluble pigments in 
fruits and vegetables, responsible for red, blue and purple colors. In plant cells, they are 
present in vacuoles in the form of various sized granules. Their basic anthocyanidin 
aglycone structures consist of an aromatic ring A bonded to a heterocyclic ring C that 
contains oxygen, which is also bound by carbon-carbon bond to a third aromatic ring B 
(Figure 1). Anthocyanins normally occur in nature in glycoside forms. The sugar moiety is 
mainly attached to the C ring (in the 3-position) or to the A ring (in the 5, 7-position). 
Glucose, galactose, arabinose, rhamnose and xylose are the most common sugars bonded to 
the anthocyanidins. These glycosylated forms are known as anthocyanins. More than 500 
different anthocyanins have been found, among which the most common is cyanidin  
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3-glucoside. The most common anthocyanidins (anthocyanins aglycones) found in nature 
are pelargonidin, peonidin, cyanidin, malvidin, petunidin and delphinidin (Figure 1) 













Anthocyanidin R1 R2 R3 
Pelargonidin H OH H 
Cyanidin OH OH H 
Delphinidin OH OH OH 
Peonidin OCH3 OH H 
Petunidin OCH3 OH OH 
Malvidin OCH3 OH OCH3 
Fig. 1. Chemical structures of anthocyanidins (Prior and Wu, 2006). 
2.3.2 Fate of anthocyanins in the gastro-intestinal tract  
The lack of the knowledge of anthocyanin metabolism in the gastrointestinal tract has been 
studied by many authors (Aura, 2005; Hassimotto et al., 2008; He et al., 2009; McGhie and 
Walton, 2007; Vitaglione et al., 2007). The fate of anthocyanins in the gastrointestinal tract is 
summarized in Table 1.  
 
Part of gastrointestinal tact Anthocyanin fate 
Mouth Deglycosylation?  
(McGhie and Walton, 2007; Selma et al., 2009) 
Stomach Chemical stability  
(Hassimotto et al., 2008; McDougall et al., 2005) Absorption  
(Felgines et al., 2008; Passamonti et al., 2003b)  
Small intestine Deglycosylation, degradation, absorption 
Large intestine Deglycosylation, degradation (Talavera et al., 2004) 
Table 1. Fate of anthocyanins through the gastrointestinal pathway 
There are no data of the effect of saliva on anthocyanins but some publications suggest that 
flavonoid glycosides are hydrolyzed to corresponding aglycons (McGhie and Walton, 2007; 
Selma et al., 2009).  
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In the stomach, anthocyanins remain intact due to the low pH that shifts the molecules 
toward the most stabile flavylium cation. Anthocyanins absorption takes place in the 
stomach through active transport (including transport carriers such as bilitranslocase 
(Passamonti et al., 2003b) and sodium dependent glucose transporter (Felgines et al., 2008)) 
and continues in the small intestine (Talavera et al., 2004). 
At the intestine neutral pH anthocyanins exist in equilibrium of four molecular forms 
(flavylium cation, quinoidal base, carbinol pseudobase and chalcone pseudobase) thus they 
can be easily exposed to degradation (McDougall et al., 2005). First studies showed 
degradation of anthocyanins from tart cherries to phenolic acids (Seeram et al., 2001). Later, 
their degradation was demonstrated by two steps. The first step is deglycosylation of 
anthocyanins to anthocyanidin aglycon while the second step is degradation of the formed 
aglycon to phenolic acid and aldehyde (Ávila et al., 2009; Fleschhut et al., 2006). 
Deglycosylation is the cleavage of the glycosyl moiety from anthocyanins structure to form 
anthocyanidin aglycons.  
These reactions could take place due to intestinal microflora (Aura et al., 2005b; Ávila et al., 
2009; Fleschhut et al., 2006), under intestinal conditions at pH 7 (Fleschhut et al., 2006), or 
spontaneously in the presence of intestinal epithelial cells (Hassimotto et al., 2008; Kay et al., 
2009).  
Degradation of anthocyanidin aglycon, achieved spontaneously or by microflora (Ávila et 
al., 2009; Fleschhut et al., 2006; Forester and Waterhouse, 2008), represents the breakdown of 
its heterocycle and cleavage of the C-ring to form phenolic acid and aldehyde (Keppler and 
Humpf, 2005). Spontaneous degradation is a consequence of the neutral pH because 
anthocyanidin aglycones are observed in chalcone form which is rather unstable and can be 
easily degraded (Fleschhut et al., 2006; Keppler and Humpf, 2005). Data showed that major 
degradation products of anthocyanidin aglycons degraded to corresponding phenolic acids 
(Table 2), as well to some other less present products still unidentified (Ávila et al., 2009; 
Fleschhut et al., 2006; Forester and Waterhouse, 2008). Further phenolic acids can be 
transformed to the benzoic acids in the presence of intestinal bacteria by cleavage of the 
hydroxyl group in the 4-position (Aura et al., 2005a; Selma et al., 2009). 
 
Anthocyanidin aglycon Corresponding phenolic acid  
Cyanidin Protocatechuic acid 
Delphinidin Gallic acid 
Pelargonidin 4-hydroxybenzoic acid 
Malvidin Syringic acid 
Peonidin Vanilic acid 
Petunidin 3-O-methylgallic acid 
Table 2. Degradation products of anthocyanidin aglycons 
The fastest degraded were anthocyanidin aglycons, much faster than anthocyanin 
monoglycosides (Keppler and Humpf, 2005). As well anthocyanin degradation by intestinal 
microflora was much faster than spontaneous one (Forester and Waterhouse, 2008).  
Anthocyanins that are not absorbed or degraded in the gastrointestinal tract can be excreted as 
intact forms. Unchanged anthocyanins were detected in human fecal samples 24 hours after 
blood orange juice consumption (Vitaglione et al., 2007), as well as in fecal samples collected 
from rats previously fattened by chokeberries, bilberries and grapes (He et al., 2005). 
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3. Citotoxicity/apoptosis of anthocyanins on colon cancer cells 
As mentioned above, naturally occurring dietary substances, in particular, flavonoids, have 
gained increased attention as agents interfering with processes involved in cancer 
development and progression. Among them, anthocyanins might be of particular interest 
since their daily intake is remarkably high compared to other flavonoids - it is estimated to 
vary between 180 and 215 mg (Hou, 2003) whereas the intake of other flavonoids reaches 
only 20-25 mg/day. Numerous recent studies indicate that anthocyanins are able to inhibit 
the growth of embryonic fibroblasts and of different cancer cells derived from malignant 
human tissues, suggesting their possible role as chemopreventive agents. This brings in 
focus their possible importance for public health as dietary components with preventive 
impact on cancer as well as effective, cheap and safe anticancer supplements. 
3.1 Cytotoxicity in colon and other cancer cell lines 
There are few reports on the inhibitory effects of anthocyanins on colon cancer cell growth. 
Extracts of grapes, bilberries and chokeberries rich in anthocyanins have been shown to 
inhibit the growth of human malignant HT-29 colon cancer cells but did not affect the 
growth of non-malignant colon-derived cells (Zhao et al., 2004). Similar effect was observed 
in highly and low tumorigenic colon cancer cell lines, LoVo/Adr and LoVo. While 
delphinidin and cyanidin were cytotoxic and induced apoptosis in the former, they failed to 
demonstrate a similar effect in the latter (Cvorovic et al., 2010). Anthocyanins from tart 
cherries significantly reduced proliferation of human colon cancer cells HT29 and HCT-116 
as well (Kang et al., 2003; Marko et al., 2004). An anthocyanins extract from Vaccinium 
uliginosum suppressed the growth of human colorectal cancer cells DLD-1 and COLO205 in 
a dose-dependent manner through the induction of apoptosis. It was hypothesized that the 
anticancer efficacy might be attributed to its high percentage of malvidin (Zu et al., 2010). 
On the other hand, the antiproliferative and the anti-cancer potential of several berry 
extracts containing different profiles of phenolic compounds (anthocyanins, flavonols, and 
ellagitannins) was studied in human colon cancer HT-29 cells. All the berry extracts studied 
decreased the proliferation and the number of HT-29 cells in the G0/G1 phase of the cell 
cycle. This correlated with their anthocyanin concentration supporting the fact that the 
inhibitory effect of berry extracts is based on the concentration rather than the composition 
of anthocyanins (Coates et al., 2007; Johnson et al., 2011; Wu et al., 2007). 
Numerous studies reported antiproliferative activity of anthocyanins in human cancer cells 
derived from malignant tissues of various origins such as breast, lung, uterus, stomach, 
central nervous system, vulva, prostate (Lazze et al., 2004; Meiers et al., 2001; Olsson et al., 
2004; Seeram et al., 2004; Zhang et al., 2005). Anthocyanins were potent and selective in 
inhibiting human promyelocytic leukemia cell proliferation as well (Feng et al., 2007; Hou et 
al., 2003; Katsube et al., 2003).  
Animal studies have also reported anticarcinogenic properties of anthocyanins. In induced 
rat colon cancer cell models they significantly decreased total tumors as well as aberrant 
crypts (Hagiwara et al., 2001; Hagiwara et al., 2002; Harris et al., 2001; Lala et al., 2006; 
Magnusson et al., 2003). Cai and colleagues demonstrated that Red grape pomace extract 
(oenocyanin) interferes with adenoma development in the ApcMin mouse by affecting tumor 
burden more prominently than tumor number. Oenocyanin efficacy was accompanied by 
the decreased adenoma cell proliferation and down-regulation of expression of the PI3 
pathway component Akt, which supports cell proliferation (Cai et al., 2010). It was also 
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demonstrated in the same animal model that anthocyanin-rich tart cherry extract added to 
the drinking water was associated with fewer and smaller tumors in the cecum, but none of 
the tested treatments influenced the number of tumors in the small intestine or the number 
or burden of tumors in the colon. It was supposed, therefore, that lack of effect of 
anthocyanins on colonic tumor development may be a consequence of their metabolism by 
intestinal bacteria or their spontaneous degradation in the cecal and colonic environment 
(Bobe et al., 2006; Kang et al., 2003). Moreover, it was shown in ApcMin mice that dietary 
consumption of anthocyanins in the form of either a mixture (Mirtoselect) or as a pure 
compound (cyanidin-3-glucoside) interferes with small intestinal adenoma development in 
a dose-dependent fashion. Authors remarked the presence of measurable levels of 
anthocyanins in the target organ and in the urine, and in concentrations near or below the 
detection limit in the systemic circulation. Unfortunately, the dietary dose, at which either 
agent was significantly efficacious when extrapolated by dose/ surface area comparison, 
suggested that equivalent for humans can be found in 740 g bilberries, that is a hefty dose. 
In terms of absolute dose of agent, cyanidin-3-glucoside was less efficacious than the 
Mirtoselect mixture. Furthermore, authors suggested that different results obtained, in 
comparison with other studies (Kang et al., 2003) were possibly due in part to the higher 
dose of anthocyanins employed but also due to the different way of administration since 
anthocyanins tend to be unstable in aqueous solution at neutral pH (Cooke et al., 2006). 
Recently, bilberry [(BB),Vaccinium myrtillus], lingonberry (LB, Vaccinium vitis-idaea), and 
cloudberry (CB, Rubus chamaemorus), rich in anthocyanins, proanthocyanidins and ellagic 
acid respectively, proved to be chemopreventive as demonstrated by a significant reduction 
in the number of intestinal tumors in Min/1 mice. Concerning their different chemical 
composition, authors suggested that the effects seen, may rather be a result of a mixture of 
compounds acting in synergy than an effect of a single active substance. Moreover, since the 
cellular levels of b-catenin are increased at all stages of colon carcinogenesis, it was 
demonstrated that two of these berries, LB and CB, markedly inhibited the growth of the 
adenomas and accumulation of nuclear b-catenin and cyclin D1. Unfortunately, also in this 
study, the amount of berries in the diets was high and could not be easily reached in a 
human diet (Misikangas et al., 2007). 
Concerning other tumor models, the incidence, multiplicity and final mass of mammary 
tumors were significantly reduced in rats that would receive grape juice containing 15 
different anthocyanins (Singletary et al., 2003). Cyanidin-3-glucoside reduced the size of 
lung cancer xenografts and significantly inhibited metastasis in nude mice (Ding et al., 
2006). Lyophilized black raspberries prevented the development of NMBA (N-
nitrosomethylbenzylamine)-induced esophageal tumors (Stoner et al., 2007), just like 
anthocyanin-containing pomegranate extract delayed the onset and reduced the incidence of 
DMBA (7,12-dimethylbenzanthracene)-induced skin tumors in CD-1 mice.  
Epidemiological studies in humans are, however, still scarce and contradictory. Biopsies of 
tumor and normal-appearing tissues in colon cancer patients consuming black raspberry 
powder daily during several weeks, showed reduced proliferation and increased apoptosis 
in cancerous but not in normal tissue. Antiangiogenic effect was also observed in these 
patients (Wang et al., 2007). A phase I pilot study in colorectal cancer patients demonstrated 
that treatment with black raspberries caused positive modulation of biomarkers of tumor 
development, including cell proliferation, apoptosis, angiogenesis and Wnt pathway in both 
colorectal adenocarcinomas and adjacent normal tissues (Wang et al., 2007). In a clinical 
pilot study twenty-five colorectal cancer patients, scheduled to undergo resection of primary 
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tumor or liver metastases, received different amount of mirtocyan. This is a standardized 
anthocyanin mixture extracted from bilberries administered daily for 7 days before surgery. 
In the immunohistochemical observations of colorectal tumors from all patients who had 
received mirtocyan, in comparison with the preintervention biopsy, the proliferation index, 
reflected by Ki-67 staining, was significantly decreased by 7%. The apoptotic index in 
colorectal cancer samples from all patients increased from 3.6% to 5.3% of epithelial cells. 
However, in the absence of a zero dose control group, authors couldn’t determine if this 
increase could, at least, to some extent, be the consequence of inherent procedural 
differences in measurements. Nevertheless, the pharmacodynamic changes observed 
seemed to be more prominent in patients at a dose of anthocyanins, which elicited target 
tissue levels below the detection limit, than at higher one, which furnished detectable 
anthocyanin levels in colorectal tissue (Thomasset et al., 2009). 
However, an Italian study aimed at investigating the relationship between anthocyanidins 
intake and risk for oral or pharyngeal cancer did not show any significant association (Rossi 
et al., 2007). There was no protective effect demonstrated on the development of prostate 
cancer either (Bosetti et al., 2006). Optimal tumor inhibition occurs when the berry 
anthocyanins are added to the diet before, during and after treatment with carcinogens, 
suggesting that consumption of berries throughout life may maximize their 
chemopreventive effectiveness in humans. The fact that berry diets show a variable effect on 
tumorigenesis suggests that the inhibitory components of berry extract are not completely 
absorbed and/or that molecules housed in berry extracts do not affect certain critical 
signaling pathways of carcinogenesis (Stoner, 2009). Although further proves are needed, 
these studies open a possibility for anthocyanins to be considered for use in cancer 
treatment in combination with other therapeutic methods. 
3.2 How anthocyanins work – The mechanisms 
Antimutagenic and anticarcinogenic activity of anthocyanins is generally ascribed to their 
antioxidant properties conveyed by their phenolic structure. The double bonds in the ring 
and the hydroxyl side chains confers them potent free-radical scavenging activities (the 
positively charged oxygen atom in their molecule makes them more generous hydrogen-
donating antioxidants compared to other flavonoids), but also enables their metal chelation 
and protein binding properties (Kong et al., 2003). Apart from acting as direct free-radical 
scavengers, anthocyanins have been demonstrated to affect the activity of phase II enzymes 
well-known for their detoxifying and antioxidant properties and therefore important in 
cancer prevention. In vivo studies showed that the diet supplemented with freeze-dried 
blueberries or black raspberries, both rich in anthocyanins, led to increased glutathione S-
transferase (GST) activity in rats (Boateng et al., 2007; Reen et al., 2006). On the other hand, 
intake of an anthocyanin-rich mixed berry juice reduced oxidative DNA damage in 
peripheral-blood mononuclear cells and significantly increased total glutathione (GSH) level 
and GSH status in whole blood in male healthy non-smoking probands (Weisel et al., 2006). 
All this speaks in favor of a multi-level antioxidant activity of anthocyanins.  
However, numerous recent studies, on the anthocyanins role in tumor growth inhibition, 
point at their prooxidant properties. It has been shown that the apoptotic effect of 
anthocyanins in malignant cells could be result of their ability to induce ROS accumulation 
in these cells. Moreover, the apoptotic activity was directly correlated to the number of 
hydroxyl groups at the B-ring (Hou et al., 2003). Interestingly, ROS generation was observed 
in leukemia cells treated with cyanidin-3-rutinoside, but not in normal human peripheral-
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blood mononuclear cells. Parallel with the accumulation of ROS, Feng and colleagues 
demonstrated the increase of peroxides, but not superoxides in these cells, suggesting the 
reaction with the glutathione antioxidant system as one of the possible mechanisms for this 
prooxidant activity, together with ROS-dependent activation of p38 and JNK (Feng et al., 
2007). Similarly, both delphinidin and cyanidin, showed prooxidant activity and induced 
apoptotic changes and cytotoxic effect in metastatic colorectal drug-resistant cells 
(LoVo/ADR), but not in cells originating from primary tumor site, Caco-2 (Cvorovic et al., 
2010). This “inconsistent” behavior of the anthocyanidins might be influenced by cellular 
energy metabolism changes associated with neoplastic transformation (Warburg, 1956b). 
Indeed, the rate of lactate production is significantly higher in highly tumorigenic 
LoVo/ADR than in low tumorigenic LoVo cells (Fanciulli et al., 2000), and, presumably, in 
CaCo-2 as well. And even a slight decrease of pH might favor protonation of 
anthocyanidins, a mechanism causing loss of their free-radical scavenging activity 
(Borkowski et al., 2005). However, it is not clear if anthocyanidins directly promote 
oxidative stress in LoVo/ADR cells. One of the possible mechanisms proposed in this study 
is the interference with the glutathione antioxidant system. Delphinidin and cyanidin 
inhibited glutathione reductase (GR) activity in LoVo/ADR cells and significantly depleted 
their intracellular glutathione levels, while failing to induce any similar effect in CaCo-2 
cells. These studies give evidence that anthocyanins preferentially kill cancer cells with high 
malignant characteristics and resistant to conventional treatment regimens, which could set 
the basis for the development of new sensitizing agents in the treatment of metastatic 
disease.  
4. Biochemical features accompanying cytotoxicity/apoptosis 
4.1 Membrane transport of anthocyanins 
All the metabolic actions exerted by anthocyanins imply their cellular bioavailability. 
Previous in vivo studies have reported that anthocyanins are absorbed in the stomach and 
small intestine (Passamonti et al., 2003a; Talavera et al., 2003; Talavera et al., 2004). Felgines 
and colleagues administered an oral dose of a radiolabelled cyanidin 3-O-glucoside, 
demonstrating that the major site of absorption in mice is the intestine with a minimal 
accumulation of the radioactivity in tissues out of the gastrointestinal tract (Felgines et al., 
2010). 
Intestinal barrier is impermeable to most flavonoid glucosides because, based on their 
molecular structure, anthocyanins and their aglycones cannot cross the cell membrane 
passively (Dreiseitel et al., 2009). Among the influx carriers, the hexose transporters SGLT1 
and GLUT 5 are expressed on apical membrane of the intestinal epithelium. Different 
groups suggested that anthocyanins, based on their glycosides moiety, could be transported 
by glucose carrier SGLT1. However, the involvement of this protein it is not completely 
understood (Milane et al., 2007; Talavera et al., 2004; Wolffram et al., 2002). 
Recently, it was also demonstrated that GLUT2, another glucose transporter, is expressed 
not only at the basolateral but also at apical membranes of intestinal cells. Faria and 
colleagues showed that kinetic parameters of 3H-2-deoxy-D-glucose-uptake of GLUT2 are 
changed after acute treatment with anthocyanins, supporting a favorable use of 
anthocyanins in diabetic population. Interestingly they also observed an increased GLUT2 
expression (not for SGLT1 or GLUT5) after a chronic exposure to anthocyanins speculating 
that this behavior could increase their own bioavailability (Faria et al., 2009). 
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Bilitranslocase (BTL) is an organic anions transporter specific for bilirubin, initially found in 
the membranes of hepatic sinusoidal cells, but present also at the gastric mucosa and in 
renal tubules (Baldini et al., 1986; Elias et al., 1990; Sottocasa et al., 1989). Some of its 
substrates are nicotinic acid, bromosulfophthalein, cibacron blue and some flavonoids 
(Passamonti et al., 2009; Passamonti et al., 2002). Among flavonoids family, 17 anthocyanins 
showed competitive inhibitory behavior to specific transport assay with delphinidin as the 
most active molecule (Passamonti et al., 2002). It was also demonstrated that the BTL is 
directly involved in the vasoactivity of flavonoids: vasorelaxation induced by both, cyanidin 
3-glucoside and bilberry anthocyanins, was significantly decreased in aorta rings pre-treated 
with anti-BTL antibodies (Ziberna et al., 2011). Recent studies have revealed that 
bilitranslocase is also expressed at the intestinal epithelial level, in particular, at the apical 
domain. Caco-2 cells express BTL as well and the uptake of BSP into these cells is strongly 
inhibited by anti-bilitranslocase antibodies (Passamonti et al., 2009). 
The results reported should be further implemented to clarify the involvement of the influx 
membrane transporters. 
More data are available on flavonoids efflux transporters. Major interest on these proteins is 
linked to their involvement in cancer resistance. These proteins belong to the class of the 
ABC transporters (ATP-binding cassette), and their role in cancer cells is to prevent the 
accumulation of anticancer drugs. Some ABC transporters are MRP1 (multidrug resistance-
associated protein 1, ABCC1) (Cole et al., 1992), MRP2 (ABCC2) and MRP3 (ABCC3) (Borst 
et al., 1999) as well as BCRP/MXR1 (ABCG2) (Doyle et al., 1998; Miyake et al., 1999) and 
Breast Cancer Resistance Protein BCRP (ABCG2) however, P-glycoprotein (ABCB1) is 
overexpressed to the highest level and plays the major role. It was shown that flavonoids 
interact with these transporters but their effects are often contradictory depending on the 
type of cancer cells (Di Pietro et al., 2002). Moreover, a different behavior depending on the 
molecular structure was also demonstrated. Dreiseitel and colleagues showed that, 
depending on the sugar moiety, some flavonoids can act as BCRP stimulators while others 
act as inhibitors (Dreiseitel et al., 2009; Morris and Zhang, 2006).  
However, the significance of these flavonoid–efflux transporter interactions has not been 
unequivocally demonstrated since it is impossible to exclude the involvement of other drugs 
transporters and of intracellular metabolizing enzymes that modify the substrate disposition 
(Morris and Zhang, 2006).  
4.2 Oxidative stress and apoptosis 
Reactive oxygen species (ROS) and reactive nitrogen species (RONS) are a collective term 
that broadly describes O2-derived free radicals such as superoxide anions (O2−), hydroxyl 
radicals (HO), peroxyl (RO2) and alkoxyl radicals (RO), nitrogen monoxide (NO), 
peroxynitrite (ONOO-), nitrogen dioxide (NO2) as well as O2-derived non-radical species 
such as hydrogen peroxide (H2O2) (Halliwell and Cross, 1994). Both reactive species are 
important mediators in the normal regulation of different physiological processes such as 
cellular proliferation or activation. On the other hand, the imbalance of cellular redox 
homeostasis is described at the base of many chronic diseases and is also involved in cancer 
development (Acharya et al., 2010).  
Specific ROS such as H2O2 or superoxide have been implicated as crucial mediators of 
apoptotic cell death (Casado et al., 2002; Circu and Aw, 2010; Madeo et al., 1999). ROS tend 
to enhance survival or promote cell death by activating different factors such as members of 
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the mitogen-activated protein kinases (MAPKs), phosphatidylinositol-3-kinase (PI3K)/Akt 
pathway, phospholipase C-g1 (PLCg1) signaling, protein kinase C, p53 signaling, ataxia-
telangiectasia-mutated (ATM) kinase, nuclear factor-kappaB (NF-kB) signaling, and Jak/Stat 
pathway. ROS modulate the apoptotic signaling pathway through the cellular redox status 
by activating key protein kinases (Chan et al., 2010; Noguchi et al., 2005). Pro-oxidants such 
as H2O2 or other stressors, could induce apoptosis (or programmed cell death) by activating 
the intrinsic or “mitochondrial” apoptosis pathway that results in the damage of this sub-
cellular compartment and the pro-apoptotic factors release (Circu and Aw, 2010; Mates et 
al., 2008). ROS involved in apoptosis derive both from environmental pro-oxidants or from 
intracellular respiratory dysfunction since mitochondria are the main site of intracellular 
source of ROS production. It was reported that oxidative stress plays an important role in 
the molecular mechanism of colorectal cancer (Keshavarzian et al., 1992) Flavones in HT-
29 colon cancer cells increase the uptake of pyruvate or lactate into mitochondria, which is 
followed by an increase in O2- production that finally leads to apoptosis (Wenzel et al., 
2005).  
The prooxidant activity of anthocyanins through the increase of intracellular ROS 
production has been clearly explained in several studies (Feng et al., 2007; Hou et al., 2005). 
4.3 GSH role in apoptosis 
Intracellular glutathione (GSH) is a major buffer of cellular redox status due to its active SH-
group that has reducing nucleophilic properties (Meister, 1983; Meister, 1991; Meister and 
Anderson, 1983). It acts as reducing agent, antioxidant and free-radical scavenger against 
ROS generated during oxidative metabolism and/or oxidative stress (Donati et al., 1990; 
Hall, 1999a; Hall, 1999b; Sies, 1999) and is also involved in the metabolism of xenobiotics 
and some cellular molecules (Wu et al., 2004). Free glutathione is present mainly in its 
reduced form maintained by the action of glutathione reductase (GR), but chemical 
oxidation of GSH to GSSG can occur as a result of numerous enzyme-catalysed reactions 
that use GSH to reduce hydrogen peroxide or other peroxides to water or the corresponding 
alcohol (Diaz Vivancos et al., 2010). GSH is preferentially (85-90%) located in the cytosolic-
nuclear compartments and only a small amount is present in mitochondria and endoplasmic 
reticulum (Hwang et al., 1992; Meredith and Reed, 1982). The free-radical and antioxidant 
action of GSH depends on its involvement in different enzymatic reactions as those 
catalyzed by glutathione peroxidases (GPxs) (Lei, 2002), glutathione-S-transferases (GSTs), 
formaldehyde dehydrogenase, maleylacetoacetate isomerase, and glyoxalase I (Arrigo, 1999; 
Dickinson and Forman, 2002; Dickinson et al., 2002; Hayes and McLellan, 1999). Cancer cells 
present elevated GSH levels that generally increase antioxidant capacity and resistance to 
oxidative stress and regulate different mechanisms linked to carcinogenesis, sensitivity 
against cytotoxic drugs, ionizing radiation, and some cytokines, DNA synthesis, and cell 
proliferation (Estrela et al., 2006). There are yet a few reports on the possible role of 
flavonoids, as well as other phytochemicals, in modulating the glutathione antioxidant 
system activity, including regulation of GSH intracellular levels through targeting its 
synthesis (Ramos and Aller, 2008), induction of MRP-1 mediated GSH efflux (Kachadourian 
and Day, 2006), or inhibition of glutathione peroxidase enzyme activity (Trachootham et al., 
2006). Upon grape seed extract treatment, HT29 colon cancer cells showed increased ROS 
production (that might result in oxidative stress in cells) and a decreased level of 
intracellular reduced glutathione (Kaur et al., 2011). In addition, after delphinidin and 
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cyanidin treatment in primary (Caco-2) and metastatic (LoVo and LoVo/ADR) colorectal 
cancer cell lines, no significant changes in the total GSH levels were observed in Caco-2 and 
LoVo cells, while both were shown to deplete intracellular glutathione levels in LoVo/ADR 
cells. GSSG content was not measurable in Caco-2 and LoVo cells, suggesting a normal 
cellular GSH/GSSG ratio (30:1–300:1) (Cvorovic et al., 2010). Cells undergoing apoptosis 
appear to rapidly and selectively release GSH into the extracellular space (Ghibelli et al., 
1995; Ghibelli et al., 1998; Hammond et al., 2007). Hammond and colleagues demonstrated 
that apoptotic GSH export is directly linked to MRPs. Indeed basal and apoptotic GSH 
releases were decreased after RNAi reduction of MRP1 expression in Jurkat cells, indicating 
that MRP1 is a major player in both processes (Hammond et al., 2007). MRP1-channelled 
GSH export from cells can be also increased by different xenobiotics, including arsenite, 
verapamil (VRP), and some naturally-occurring flavonoids (Leslie et al., 2003; Loe et al., 
2000). 
GSTs are known as a family of Phase II detoxification enzymes that catalyze the conjugation 
of GSH (S-glutathionylation) with different compounds as xenobiotics and drugs or their 
metabolites, to form mercapturates (Hayes et al., 2005).  
It has been recently shown that anthocyanin fractions from selected cultivars of Georgia-
Grown Blueberries at 50-150 íg/mL do induce apoptosis in HT-29 colon cancer cells but 
these same concentrations decrease GST activities rather than induce it (Srivastava et al., 
2007). 
There are several studies, in normal cells and tissues, in which it was demonstrated that 
anthocyanins, probably involving some protein kinases, modulate the activity of some GSH-
dependent enzymes, thus ameliorating the antioxidant response (Hou et al., 2010; Suda et 
al., 2008; Veigas et al., 2008).  
GSSG formed intracellularly is continuously reduced to GSH by the activity of GR. If 
oxidative stress or other factors limit the GR activity (e.g., glucose-6-phosphate 
dehydrogenase deficiency may limit NADPH supply), GSSG will accumulate (Deneke and 
Fanburg, 1989). In this respect, Cvorovic and colleagues showed that delphinidin and 
cyanidin did inhibit GR activity in LoVo/ADR cells but not in Caco2 and Lovo cells 
(Cvorovic et al., 2010). This has two important consequences: (i) the thiol redox status of the 
cell will shift, activating oxidant response transcriptional elements; and (ii) GSSG may be 
preferentially secreted out of the cell. (i) The protein sequences of many transcription factors 
contain cys residues, mainly localized in the DNA-binding domain that, when oxidized, 
cause a different modulation of gene expression (Arrigo, 1999). (ii) GSSG may be reduced 
back to GSH, but when GSSG is present in excess, it is also eliminated from the cell by 
export into the extracellular space. Strong evidence that this export step is mediated by 
MRP2 was provided by studies of GSSG transport with canalicular membrane-enriched 
vesicles derived from normal and EHBR (Eisai hyperbilirubinuric rats) rats (Ballatori et al., 
2009). 
4.4 Intracellular pH and apoptosis 
Despite the genetic variability, two phenotypes common to all tumor cells are cellular 
alkalinization and a shift to glycolytic metabolism. In the first decade of the 20th century, 
Otto Warburg found that cancer cells, even in the presence of oxygen disposition and a 
higher request of ATP for fast growing cells, prefer to metabolize glucose via glycolysis 
instead of oxidative phosphorylation (Warburg, 1956a). The oxygen levels within a tumor 
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vary both spatially and temporally. The elevated glycolytic pathway of cancer cells appears 
to be a response to hypoxia due to the growth of the tumor surpassing the available vascular 
supplied oxygen (Mathupala et al., 2001) and seems to be controlled directly by the 
antiapoptotic protein Akt that generates apoptotic resistance in vitro (Elstrom et al., 2004). 
Then, the decreased dependence on aerobic respiration becomes a selective advantage for 
survival and proliferation escaping from the apoptotic event. Cell metabolism is shifted 
toward the increased expression of glycolytic enzymes, glucose transporters, and inhibitors of 
mitochondrial metabolism that result in a transitional intracellular acidification (Hsu and 
Sabatini, 2008) and increased glucose uptake is observed coincident with the transition from 
colon adenomas to invasive cancer (Yasuda et al., 2001). Nevertheless, evidence that 
intracellular acidification is associated with the progression of apoptosis, has been steadily 
accumulating (Barry et al., 1993; Gottlieb et al., 1996; Li and Eastman, 1995; Rebollo et al., 1995).  
An important role in the intracellular acidification could be due to alterations of membrane 
pHi-regulating mechanisms, including the Na+/H+ exchanger (NHE) that might favor 
accumulation of the protons produced by energetic metabolism. NHE is ubiquitously 
expressed transporter in the plasma membrane with a main function to extrude H+ from the 
cytoplasm.  
Multidrug resistant tumor cells exhibit an altered pH gradient across different cell 
compartments, which favors a reduced intracellular accumulation of antineoplastic drugs 
and a decreased therapeutic effect. In fact, the activity and expression of NHE are increased 
in doxorubicin-resistant (HT29-dx) human colon carcinoma cells in comparison with 
doxorubicin-sensitive HT29 cells (Miraglia et al., 2005). On the other hand, it was 
demonstrated that activation of the NHE-1 and the resulting cellular alkalinization play a 
key role in oncogenic transformation (Reshkin et al., 2000). Cyanidin (10 microM), but not its 
glycosides, could inhibit the neurotensin- and EGF-induced increased rate of 
extracellular acidification in HT-29 human colon adenocarcinoma cell line probably by 
inhibiting cellular metabolism, rather than directly altering Na+/H+ exchange (Briviba et 
al., 2001).  
The effect of anthocyanins on metabolism involved in pH modulation of apoptosis is 
anyway a poor-trodden path. 
5. Roadmap for further investigations 
5.1 Role of flavonoids on DNA methylation 
In humans, multistage carcinogenesis was previously considered a consequence of genetic 
alterations that cause activation of oncogenes and inactivation of tumor suppressor genes. In 
addition to genetic events, epigenetic events are another leading player in carcinogenesis 
(Link et al., 2010). Indeed, it is believed that majority of cancers result from changes that 
accumulate throughout the life due to the exposure to various endogenous factors and 
arguably diet and environment-mediated epigenetic perturbations play a crucial role in 
cancer progression in humans (Herceg, 2007). It was first recognized more than 25 years ago 
that in colorectal cancer cells, global DNA methylation patterns differed considerably from 
those in their normal counterparts (Venkatachalam et al., 2010).  
The developmental biologist Conrad H. Waddington coined the term ‘epigenetics’ in 1942, 
trying to describe reversible heritable changes in gene expression that occur without 
alteration in DNA sequence sufficiently powerful to regulate the dynamics of gene 
expression (Waddington, 1951 as cited in (Hitchler and Domann, 2009).  
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One of the “epigenome” processes is DNA methylation, a covalent chemical modification 
resulting in addition of a methyl (CH3) group at the carbon 5 position of the cytosine ring in 
CpG dinucleotides (Kanai and Hirohashi, 2007). This process plays important roles in 
chromatin structure modulation, transcriptional regulation and genomic stability, and is 
essential for the development of mammals (Ducasse and Brown, 2006; Li, 2002). CpG 
dinucleotides are not uniformly distributed throughout the human genome, but are often 
enriched in the promoter regions of genes. Short CpG-rich regions are also called as ‘‘CpG 
islands’’, and these are present in more than 50% of human gene promoters and can lead to 
gene silencing and proliferation or to affect the metabolic processes associated with energy 
metabolism. (Link et al., 2010). This mechanism is an enzymatic process mediated by DNA 
methyltransferases (DNMT): DNMT1, also called a “maintenance methyltransferase”, 
preserves existing methylation patterns following DNA replication; DNMT3a and DNMT3b, 
on the other hand, serve as de novo methyltransferases, which act independently of 
replication on both strands, altering the epigenetic information content (Yu et al., 2011).  
Recent studies havedemonstrated that all three DNMTs are overexpressed in several tumor 
types, including tumors of the colon and rectum, bladder, and kidney. When DNMT1 and 
DNMT3b are knocked out in colon cancer cell lines, methylation of tumor suppressor genes 
such as p16 is almost entirely eliminated and the gene is re-expressed (Rhee et al., 2002), as 
well as it has been established that the inhibition of DNA methyltransferase activity can 
strongly inhibit the formation of tumors (Stresemann et al., 2006).  
It is known that some nutrients like folic acid, B vitamins and SAM (S-adenosylmethionine) 
and anthocyanins are key components of the methyl-metabolism pathway (Vanzo et al., 2011). 
Their methyl-donating mechanism can rapidly alter gene expression by modulating the 
availability of methyl donors as well as DNMT activity (Ross, 2003). There is a growing 
interest in the role of polyphenols in prevention of DNA methylation. It was demonstrated 
that epigallocatechin-3-gallate (EGCG), a tea polyphenol, through its methylation exerted by 
catechol-O-methyltransferase (COMT), indirectly inhibited DNMT. Indeed, S-adenosyl-L-
homocysteine (SAH), produced by COMT reaction is a potent inhibitor of DNMT (Fang et al., 
2003). On the other hand, EGCG can directly inhibit DNMT through the hydrogen bonds 
formation with different residues in the catalytic pocket of the enzyme (Lee et al., 2005). 
Moreover, Fang et al. showed that reactivation of some methylation-silenced genes by EGCG 
was also demonstrated in human colon cancers and prostate cancer cells (Fang et al., 2003). 
5.2 Apoptosis and ATP/ADP ratio  
Oxygen consumption in cells is regulated by a respiratory control system which depends on 
ADP and Pi. When the amount of ATP is high, the amount of ADP is limited and therefore, 
use of oxygen declines. In other words, oxygen consumption increases as the need for ATP 
arises (Valle et al., 2010). ATP generation through oxygen conversion is not a fully efficient 
process because a percentage of the energy of the electrochemical gradient is lost and not 
coupled to ATP production (Matsuyama and Reed, 2000). This situation arises due to a 
phenomenon called ‘proton leak’ which causes protons to return to the mitochondrial 
matrix via alternative pathways that by-pass ATP synthase (Brand, 1990; Brown and Brand, 
1991; Valle et al., 2010). Lynen suggested that the increased dependence of cancer cells on 
glycolysis stemmed not from their inability to reduce oxygen, but rather from their inability 
to synthesize ATP in response to the mitochondrial proton gradient (Lynen, 1951 as cited in 
(Samudio et al., 2009). 
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Although, some explanations for the ‘proton leak’ come from the biophysical properties of the 
inner membrane, much of the explanation comes from the activities of a family of 
mitochondrial proteins termed uncoupling proteins (UCPs) (Klingenberg, 1999; Valle et al., 
2010). UCPs exploit the gap in pH concentration to transfer the proton through the inner 
membrane into the matrix where they are released. Consequently, the mitochondrial 
membrane potential decreases, reduction of O2 via the respiratory chain is no longer linked to 
ATP synthesis and ATP/ADP exchange is not longer maintained (Vander Heiden et al., 1999). 
The influence of anthocyanins on ATP/ADP ratio and on UCPs role could be the aim of 
further studies. 
5.3 Apoptosis and oxygen consumption 
Cancer cells seem to show high glycolytic rates even when oxygen is sufficient for oxidative 
phosphorylation (OXPHOS). This condition leads to a survival benefit of the tumor 
providing protection from oxidative stress and resulting in apoptosis avoidance (Kondoh et 
al., 2007a; Kondoh et al., 2007b). The importance of glycolysis in the survival of cancer cells 
was demonstrated by Bonnet and colleagues. Their experimental approach aimed at 
inhibiting the anaerobic glycolisys by repressing the activity of pyruvate dehydrogenase 
kinase (PDK) with dichloroacetate (DCA). PDK acts as a negative modulator of pyruvate 
dehydrogenase, a gate-keeping mitochondrial enzyme which controls the glucose oxidative 
fate into the cell. DCA changes the metabolism of cancer cells from the cytoplasm-based 
glycolysis to the mitochondria- based glucose oxidation. This led to increased ROS 
production and decreased mitochondrial membrane potential, efflux of pro-apoptotic 
mediators from mitochondria, and induction of mitochondria-dependent apoptosis only in 
cancer cells (Bonnet et al., 2007). On the other hand, in the majority of mammalian cells, 
glycolysis is inhibited by the presence of oxygen, which allows the mitochondria to oxidize 
pyruvate to CO2 and H2O.  
The transcription factor p53 regulates cellular energy metabolism and antioxidant defense 
mechanisms. Emerging evidence has shown that these two functions of p53 contribute 
greatly to p53’s role in tumor suppression (Bensaad and Vousden, 2007; Matoba et al., 2006; 
Sablina et al., 2005). Loss of p53 results in decreased oxygen consumption and impaired 
mitochondrial respiration and promotes a switch to high glucose utilization in aerobic 
glycolysis in cells (Maddocks and Vousden). 
It was shown that p53 regulates the OXPHOS dependence of cell by modulating the 
assembly of a key complex in the mitochondrial electron chain transport: cytochrome c 
oxidase (COX) (Ma et al., 2007; Matoba et al., 2006). It was demonstrated, in fact, that in 
HCT116 cells, p53 controls the expression of SCO 2 (Synthesis of Cytochrome c Oxidase 2). 
SCO2 is required for the assembly of mitochondrial DNA-encoded COX II subunit (MTCO2 
gene) into the COX, so, p53 directly regulates mitochondrial oxygen consumption. p53 
mutations in cancer cells induce a loss in SCO2, thereby resulting in a switch from an 
aerobic mitochondrial respiration to anaerobic glycolysis. p53 induces SCO2 expression to 
enhance mitochondrial respiration and induces TIGAR expression to slow glycolysis (Won 
et al., 2011).  
The metabolic implications of anthocyanins through the oxidative use of glucose could be 
appreciated indirectly. In fact, it is known that anthocyanins induce p53 expression 
(Fimognari et al., 2005; Lo et al., 2007; Renis et al., 2008), but a direct involvement of this 
compounds on glucose metabolic use it is not yet demonstrated. 
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The different observations found in epidemiological studies in comparison to the in vitro 
ones are linked, partly to the relatively low flavonoid intake and complexity of metabolism 
in humans, and partly to the lack of adequate molecular biomarkers for monitoring the 
earliest stages of disease development in humans (Pierini et al., 2008). Moreover, the 
relevance of the in vitro studies to the in vivo situation needs to be confirmed in view of the 
high concentrations of polyphenols employed in the in vitro studies. 
All the data recorded about the role of polyphenols and flavonoids has been obtained 
through the use of classical cell biology and biochemistry methods. Maybe nutrigenomics, 
that is the study of the effects of foods and food constituents on gene expression could 
deepen our understanding of these and other phytochemicals (Corthesy-Theulaz et al., 2005; 
Davis and Hord, 2005; Mariman, 2006).  
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